DrugPatentWatch Database Preview
US Patent Family Members and Approved Drugs for United States of America Patent: 2017081326
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for United States of America Patent: US2017081326
US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|
Start Trial | 2035-09-21 | asparaginase | Merck | ELSPAR |
Start Trial | 2035-09-21 | rituximab | Genentech | RITUXAN |
Start Trial | 2035-09-21 | trastuzumab | Genentech | HERCEPTIN |
Start Trial | 2035-09-21 | alemtuzumab | Genzyme | CAMPATH |
Start Trial | 2035-09-21 | alemtuzumab | Genzyme | LEMTRADA |
Start Trial | 2035-09-21 | ibritumomab tiuxetan | Spectrum Pharms | ZEVALIN |
>US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |